These results suggest that ethyl acetate and methanol extracts may contain bioactive compounds that can control neurodegenerative disorders, including Alzheimer’s disease, through high antioxidant, anti-inflammatory, and anti-AChE activities. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.